EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring the prognostic value and potential therapeutic strategies of MS4A6A in glioblastoma: A comprehensive analysis of single‐cell and multi‐omics data

Fangchao Wan, Yanling Li, Jianming Zhu, Dandan Yu, Hongjuan Liu, Bohong Hu iD

Journal of Cellular and Molecular Medicine · 2024

DOI: 10.1111/jcmm.70177 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Fangchao Wan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Changde Hospital, Xiangya School of Medicine, Central South University, Changde, Hunan, China. Hauptthemen laut MEDLINE: Glioblastoma, Tumor Microenvironment, Single-Cell Analysis, Brain Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hunan Provincial Health and Wellness Commission for Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) is a highly aggressive and treatment‐resistant malignancy that poses a significant challenge in modern medicine. Despite advances in surgical resection, radiotherapy and chemotherapy, complete eradication of GBM remains elusive due to its diffuse invasion into the brain parenchyma and propensity for recurrence. The tumour microenvironment (TME), particularly macrophages, has emerged as a critical player in GBM progression, invasion and metastasis. In the immune microenvironment of glioma, MS4A6A exhibits unique expression characteristics in macrophages. This study aimed to investigate the potential role of MS4A6A, a gene associated with aging and neurodegenerative diseases, in GBM and its potential as a prognostic biomarker and therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaTumor MicroenvironmentSingle-Cell AnalysisBrain NeoplasmsHumansPrognosisBiomarkers, TumorGene Expression Regulation, NeoplasticMacrophagesMultiomics

Stichwörter der Autor:innen

MS4A6Agliomamulti‐omicssingle cell

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Neurology, Changde Hospital, Xiangya School of Medicine, Central South University, Changde, Hunan, China.
  • Department of Electrocardiogram, Changde Hospital, Xiangya School of Medicine, Central South University, Changde, Hunan, China.

ORCID-Profile: Bohong Hu

Förderung

  • Hunan Provincial Health and Wellness Commission for Health Research

Zitieren

APA

Wan, F., Li, Y., Zhu, J., Yu, D., Liu, H., & Hu, B. (2024). Exploring the prognostic value and potential therapeutic strategies of MS4A6A in glioblastoma: A comprehensive analysis of single‐cell and multi‐omics data. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70177

Vancouver

Wan F, Li Y, Zhu J, Yu D, Liu H, Hu B. Exploring the prognostic value and potential therapeutic strategies of MS4A6A in glioblastoma: A comprehensive analysis of single‐cell and multi‐omics data. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.70177

BibTeX
@article{Wan2024,
  author = {Wan, Fangchao and Li, Yanling and Zhu, Jianming and Yu, Dandan and Liu, Hongjuan and Hu, Bohong},
  title = {Exploring the prognostic value and potential therapeutic strategies of MS4A6A in glioblastoma: A comprehensive analysis of single‐cell and multi‐omics data},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  doi = {10.1111/jcmm.70177}
}
Kostenlos starten →